Clinical Trials

  • Principal Investigator:

    Jon Tyler Giles, MD
    If you currently live in the same household as someone who has tested positive for novel coronavirus (COVID-19), you might be eligible to participate in a trial that will test if a medicine used to prevent malaria, hydroxychloroquine, might reduce the risk of your developing COVID-19 symptoms. COVID-19 is a massive threat to public health worldwide. Post-exposure prophylaxis in other words, treating people who have been exposed to an infection in order to reduce the risk that they will develop the disease is a strategy that has been used successfully for seasonal influenza (e.g., Tamiflu) and...
  • Principal Investigator:

    Elana J. Bernstein, MD, MSc
    The purpose of this study is to find out whether a drug called iloprost is safe to use in people with systemic sclerosis (SSc) (Raynaud's phenomenon), and whether it may help decrease symptomatic digital ischemic episodes (episodes in the fingers).
  • Principal Investigator:

    Elana J. Bernstein, MD, MSc
    The purpose of this study is to develop a cohort of patients with early scleroderma and to collect data on clinical outcomes, radiological tests, laboratory tests, and to obtain biological specimens for testing.
  • Principal Investigator:

    Elana J. Bernstein, MD, MSc
    This research is being done to determine how variations in genes may explain the different risk to develop scleroderma (or CREST) seen in African American patients compared to other populations. People who are African American with scleroderma (or CREST) may join. This research involves a blood draw and physical exams.